Kromek Group plc (LON:KMK), a leading developer of radiation and bio-detection technology solutions for the advanced imaging and CBRN segments, has gives notice that it will be announcing its interim results for the six months ended 31 October 2021 on 18 January 2022.
Dr Arnab Basu, Chief Executive Officer, and Paul Farquhar, Chief Financial Officer, will be hosting a presentation to analysts at 9.30am GMT on the day via webcast. To register to participate, please contact: amysmart@luther.co.uk.